
Sign up to save your podcasts
Or


AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
By The Motley Fool4.7
16041,604 ratings
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.

3,229 Listeners

1,497 Listeners

807 Listeners

949 Listeners

534 Listeners

1,178 Listeners

2,189 Listeners

825 Listeners

1,422 Listeners

1,037 Listeners

9,714 Listeners

195 Listeners

835 Listeners

85 Listeners

591 Listeners

997 Listeners

52 Listeners